Incannex – Independent data review commences for Phase 2 trial of psilocybinassisted psychotherapy for anxiety
Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’), a pharmaceutical company developing proprietary medicinal cannabinoid products and… Read more